TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to its partner Alvotech (NASDAQ: ALVO) for the Biologics License Application (BLA) for AVT02, a high-concentration biosimilar candidate for Humira® (adalimumab). The CRL stated that … [Read more…]
The Colorado State Government partners with Donor Alliance in a bold commitment to raise awareness for organ, eye and tissue donation DENVER–(BUSINESS WIRE)–In a strong display of commitment, the Colorado State Government will today declare its support for organ, eye and tissue donation by becoming the nation’s first Donate Life Community state. Working alongside Donor … [Read more…]
NEW YORK–(BUSINESS WIRE)–Joseph Whitters, an Independent Board Member of CUTERA, INC., today issued the following statement in his individual capacity in light of recent events at Cutera: “As an independent Board member of Cutera, I have always believed that a seamless, collaborative, and orderly CEO succession is in the best interest of all Cutera shareholders, … [Read more…]
Focus at New Ag International Annual Conference in Barcelona will be Cutting Edge Innovation in Fertilizers and Plant Nutrition BioAg World Congress in Rio de Janeiro Presentation will Highlight BioConsortia’s Groundbreaking Nitrogen-fixing Innovation using Robust Spore-forming Microbials DAVIS, Calif.–(BUSINESS WIRE)–BioConsortia, Inc., a leader in R&D for sustainable agriculture, whose mission is to unleash the power … [Read more…]
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment of two of its business reporting segments. The financial information reflects the past two years of recast performance for Aptar’s … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2023 after the close of market on Thursday, May 4, 2023. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern … [Read more…]
The Asset Purchase Agreement allows Meilleur Technologies, Inc. to develop and commercialize markets while Navidea Biopharmaceuticals, Inc. receives additional liquidity for focused growth. DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it has signed an Asset Purchase … [Read more…]
ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) (the “Company”) today announced that Carl Feldbaum, Esq. and Vincent Marchesi, M.D., Ph.D., two long-standing and valued members of the Board of Directors, will not stand for re-election at the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”). As part of its ongoing refreshment program, the Board is … [Read more…]
QuidelOrtho to report first quarter 2023 financial results on May 3, 2023 SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the first quarter ended April 2, 2023. The Company … [Read more…]
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 28, 2023 to discuss its first quarter 2023 operating results. Management will also provide a brief update … [Read more…]
